| Member | Buys | Sells | Est. net | Last move |
|---|---|---|---|---|
| Gilbert Cisneros CA31 | 3 | +$24.0K | Bought Jun 5, 26 | |
| Rob Bresnahan PA08 | 1 | −$8.0K | Sold May 15, 25 |
| Traded | Member | Owner | Type | Amount | Filed | Report |
|---|---|---|---|---|---|---|
| Jun 5, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Jul 2, 26 (27d) | |
| May 29, 26 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Jun 8, 26 (10d) | |
| Dec 10, 25 | Gilbert Cisneros CA31 | Self | Buy | $1,001 - $15,000 | Jan 12, 26 (33d) | |
| May 15, 25 | Rob Bresnahan PA08 | Self | Sell | $1,001 - $15,000 | Jun 9, 25 (25d) |
From the House's STOCK Act reports (Senate not included). Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Kurzius Lawrence ErikDirector | Purchase at price 54.93 per share. | 10K | $549.32K |
| Sep 13, 2026 | Rosebrough Walter M JrDirector | Purchase at price 54.11 - 54.29 per share. | 10K | $541.64K |
| Sep 13, 2026 | Kurzius Lawrence ErikDirector | Purchase at price 53.92 per share. | 10K | $539.15K |
| Sep 10, 2026 | Keel Paul ADirector | Purchase at price 53.18 per share. | 4.7K | $250.00K |
| Mar 31, 2026 | Jay Colleen EDirector | — | 3.3K | — |
| Mar 31, 2026 | Rivas MariaDirector | — | 3.3K | — |
| Mar 31, 2026 | Carbone BarbaraDirector | — | 3K | — |
| Mar 31, 2026 | Kurzius Lawrence ErikDirector | — | 3.3K | — |
| Mar 31, 2026 | Rosebrough Walter M JrDirector | — | 832 | — |
| Mar 31, 2026 | Madden Teresa SmithDirector | — | 3.3K | — |
| Mar 31, 2026 | Weiss Robert SDirector | — | 3.7K | — |
| Mar 31, 2026 | Lucchese Cynthia LDirector | — | 3.3K | — |
| Jan 11, 2026 | Jay Colleen EDirector | Conversion of Exercise of derivative security at price 39.40 per share. | 7.1K | $278.32K |
| Jan 7, 2026 | Sheffield Holly ROfficer | — | 8.1K | — |
| Jan 7, 2026 | Warner Gerard H, IiiOfficer | — | 11.5K | — |
| Jan 7, 2026 | Andrews Brian GChief Financial Officer | — | 3.5K | — |
| Jan 7, 2026 | White Albert G IiiChief Executive Officer | — | 18.3K | — |
| Jan 7, 2026 | Mcbride Daniel GChief Operating Officer | — | 12.9K | — |
| Dec 21, 2025 | Lucchese Cynthia LDirector | Purchase at price 84.06 per share. | 1.8K | $149.96K |
| Dec 17, 2025 | Rivas MariaDirector | Purchase at price 82.13 per share. | 1K | $82.13K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.7 | 2.8 | -14.5 | -12.0 | -2.7 | 17.2 | 0.9 | -3.1 | -19.3 | -1.7 | −32.2% | ||
| 2025 | 5.0 | -6.4 | -6.7 | -3.2 | -16.4 | 4.2 | -0.7 | -4.7 | 1.7 | 2.0 | 11.5 | 5.2 | −10.8% |
| 2024 | -1.4 | 0.4 | 8.4 | -12.2 | 5.9 | -7.4 | 6.9 | 13.3 | 4.4 | -5.1 | -0.2 | -12.0 | −2.8% |
| 2023 | 5.5 | -6.3 | 14.2 | 2.2 | -2.6 | 3.2 | 2.0 | -5.4 | -14.0 | -2.0 | 8.1 | 12.3 | +14.4% |
| 2022 | -4.9 | 2.7 | 2.1 | -13.5 | -2.9 | -10.7 | 4.4 | -12.1 | -8.2 | 3.6 | 15.7 | 4.5 | −21.1% |
| 2021 | 0.2 | 6.1 | -0.5 | 7.0 | -4.2 | 0.7 | 6.4 | 6.9 | -8.3 | 0.9 | -9.7 | 11.3 | +15.3% |
| 2020 | 8.0 | -6.4 | -15.1 | 4.0 | 10.6 | -10.5 | -0.3 | 11.1 | 7.2 | -5.4 | 5.1 | 8.4 | +13.1% |
| 2019 | 9.5 | 2.6 | 3.6 | -2.1 | 2.7 | 13.1 | 0.2 | -8.2 | -4.1 | -2.0 | 7.6 | 2.6 | +26.2% |
| 2018 | 12.3 | -5.8 | -0.7 | -0.0 | -1.0 | 4.0 | 10.6 | -1.8 | 8.4 | -6.8 | 7.9 | -8.7 | +16.8% |
| 2017 | 5.5 | 7.9 | 0.4 | 0.2 | 9.2 | 9.4 | 1.9 | 2.9 | -5.5 | 1.3 | 0.4 | -9.7 | +24.6% |
| 2016 | -2.3 | 9.0 | 7.7 | -0.6 | 6.4 | 5.4 | 6.4 | 1.9 | -3.6 | -1.8 | -6.6 | 6.3 | +30.4% |
| 2015 | -2.7 | 4.0 | 14.3 | -5.0 | 2.1 | -2.1 | -0.5 | -8.2 | -8.3 | 2.4 | -4.0 | -8.2 | −17.2% |
| 2014 | 0.4 | 3.2 | 7.1 | -4.0 | -2.2 | 5.0 | 18.7 | 1.3 | -4.5 | 5.2 | 3.1 | -4.0 | +30.9% |
| 2013 | 9.6 | 4.6 | 1.7 | 2.3 | 2.4 | 5.3 | 7.0 | 2.6 | -0.7 | -0.4 | 2.0 | -6.0 | +33.9% |
| 2012 | 2.3 | 10.2 | 2.8 | 7.9 | -3.4 | -6.4 | -5.6 | 11.4 | 12.7 | 1.6 | -1.1 | -2.6 | +31.1% |
| 2011 | 1.8 | 7.8 | 12.3 | 7.8 | 0.0 | 5.8 | -3.5 | -1.6 | 5.2 | -12.4 | -11.6 | 15.1 | +25.2% |
| 2010 | -7.3 | 13.4 | -2.9 | 0.0 | -5.2 | 7.9 | -2.3 | 3.8 | 14.6 | 6.8 | 8.4 | 5.3 | +47.8% |
| 2009 | 15.7 | 15.9 | 20.2 | 8.7 | -7.8 | -6.7 | 11.0 | -0.4 | 8.8 | -5.8 | 19.6 | 13.8 | +132.4% |
| 2008 | 3.6 | -13.2 | 0.7 | 1.7 | 15.6 | -8.2 | -9.3 | 9.3 | -5.6 | -52.6 | -18.7 | 22.4 | −56.8% |
| 2007 | 7.2 | -3.8 | 5.9 | 5.1 | 7.9 | -3.3 | -6.0 | -2.7 | 7.5 | -19.9 | 2.5 | -11.7 | −14.6% |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Buy / hold / sell counts